BlackRock Institutional Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$19.5M	Buy	1,224,332 +119,021	+11%	+$1.91M	﹤0.01%	1984
2016 Q3	$18.4M	Sell	1,105,311 -3,543	-0.3%	-$47.7K	﹤0.01%	1951
2016 Q2	$12.4M	Buy	1,108,854 +15,575	+1%	+$151K	﹤0.01%	2159
2016 Q1	$9.14M	Buy	1,093,279 +15,237	+1%	+$125K	﹤0.01%	2316
2015 Q4	$10M	Buy	1,078,042 +21,677	+2%	+$216K	﹤0.01%	2322
2015 Q3	$11.9M	Sell	1,056,365 -69,891	-6%	-$855K	﹤0.01%	2166
2015 Q2	$14.3M	Buy	1,126,256 +15,107	+1%	+$163K	﹤0.01%	2156
2015 Q1	$10.3M	Sell	1,111,149 -26,421	-2%	-$299K	﹤0.01%	2377
2014 Q4	$16.3M	Buy	1,137,570 +82,929	+8%	+$981K	﹤0.01%	2036
2014 Q3	$10.9M	Sell	1,054,641 -12,957	-1%	-$170K	﹤0.01%	2270
2014 Q2	$17.3M	Sell	1,067,598 -12,272	-1%	-$163K	﹤0.01%	2063
2014 Q1	$17.5M	Buy	1,079,870 +34,884	+3%	+$496K	﹤0.01%	2052
2013 Q4	$13M	Buy	1,044,986 +41,444	+4%	+$416K	﹤0.01%	2241
2013 Q3	$11M	Buy	1,003,542 +91,168	+10%	+$974K	﹤0.01%	2301
2013 Q2	$7.37M	Buy	+912,374	New	+$6.14M	﹤0.01%	2493